date,title,source
Oct-17-18,"Research Report Identifies Oxford Immunotec Global, Ascena Retail Group, Groupon, Epizyme, Regulus Therapeutics, and B Communications with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Oct-18-18,Regulus Regains Compliance with NASDAQ Listing Requirements,PR Newswire
Oct-22-18,Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018,PR Newswire
Oct-23-18,3 Healthcare Stocks To Watch On Tuesday,ACCESSWIRE
Oct-23-18,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",Benzinga
Oct-25-18,"Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018",PR Newswire
Nov-06-18,Regulus Announces Successful Restructuring of Sanofi Collaboration,PR Newswire
Nov-08-18,"Regulus (RGLS) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,Regulus: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Regulus Reports Third Quarter 2018 Financial Results and Recent Updates,PR Newswire
